Second shareholder suit filed against Amgen

LOS ANGELES – A class-action suit against Amgen Inc. (Nasdaq: AMGN) was announced late yesterday by the law firm of Stull, Stull & Brody Inc. of Los Angeles and New York. “We believe the allegations have no merit,” said David Polk, Amgen’s executive director of corporate communications and media relations. It was not immediately clear…

Want More Free?

To access 2 more articles, please log in or register for free.

Registered users get access to a limited number of free articles every month.

Register Now

Already registered? Login to access more free articles.

Purchase NowWant to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.

- Advertisement -